Morphine
Compensan Retard, Morphinhydrochlorid Retard Lannacher, Mundidol, Oramorph · ATC code N02AA01
Also known as: Morphin, Morfin, Morphine Sulfate · Brand names: Compensan Retard, Morphinhydrochlorid Retard Lannacher, Mundidol, Oramorph, Substitol, Vendal, Capros, M-Beta, M-Long, M-Stada, Molnex, Morphinsulfat Abz, Morphinsulfat Dopiopharm, Morphinsulfat Gry, Morphinsulfat Hameln …
- Key facts
- Active substance
- Morphine
- Drug class
- Opioid
- ATC code
- N02AA01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Boxed warning
Addiction, Abuse, and Misuse
Because the use of Morphine Sulfate Tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)].
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of Morphine Sulfate Tablets, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Morphine Sulfate Tablets are essential [see Warnings and Precautions (5.2)].
Accidental Ingestion
Accidental ingestion of even one dose of Morphine Sulfate Tablets, especially by children, can result in a fatal overdose of morphine [see Warnings and Precautions (5.2)].
Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of Morphine Sulfate Tablets and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3), Drug Interactions (7)].
Neonatal Opioid Withdrawal Syndrome (NOWS)
Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery [see Warnings and Precautions (5.4)].
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription [see Warnings and Precautions (5.5)].
Key facts
Morphine is an opioid agonist. Per the US prescribing information, the tablets are used for acute and chronic pain severe enough to require an opioid when alternative treatments are inadequate.
What it is used for
- Acute pain in adults and pediatric patients weighing at least 50 kg, when an opioid is needed and alternatives are inadequate
- Chronic pain in adults under the same conditions
- Reserved for patients in whom other options are ineffective or inadequate, because of addiction, abuse and overdose risks
Dosing
- Lowest effective dosage for the shortest duration; prescribed by professionals knowledgeable in opioid use
- Opioid-naive adults: 15 mg to 30 mg every 4 hours as needed, then titrate to response
- Pediatric patients at least 50 kg: 15 mg every 4 hours as needed; initial dose not exceeding 30 mg
- Cirrhosis and renal failure: start with a lower dosage and titrate slowly
- Do not abruptly discontinue in physically dependent patients
- Inform patients about overdose reversal agents (e.g., naloxone); conversion schemes are in the full text
Contraindications
- Significant respiratory depression
- Acute or severe bronchial asthma in an unmonitored setting or without resuscitative equipment
- MAOIs concurrently or within the last 14 days
- Known or suspected gastrointestinal obstruction, including paralytic ileus
- Hypersensitivity to morphine
Important warnings
- Boxed warning: addiction, abuse and misuse, with risk of overdose and death
- Boxed warning: life-threatening respiratory depression, especially at initiation and after dose increases
- Boxed warning: accidental ingestion, especially by children, can be fatal
- Boxed warning: with benzodiazepines or other CNS depressants (including alcohol), profound sedation, coma and death
- Neonatal opioid withdrawal syndrome with prolonged use in pregnancy
- Adrenal insufficiency, severe hypotension, seizures, opioid-induced hyperalgesia
Side effects
- Serious: respiratory depression, apnea, circulatory depression, respiratory arrest, shock, cardiac arrest
- Common on initiation: nausea, vomiting, constipation
- Addiction, withdrawal, sedation
Interactions
- Benzodiazepines and other CNS depressants including alcohol: hypotension, respiratory depression, coma, death
- MAOIs contraindicated; further interactions in Table 1 of the label
Pregnancy and breastfeeding
- Prolonged use during pregnancy can cause neonatal opioid withdrawal syndrome
- Morphine is present in breast milk
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- Compensan RetardG.L. Pharma Gmbh · 1 register entry
- Morphinhydrochlorid Retard LannacherG.L. Pharma Gmbh · 2 register entries
- MundidolMundipharma Gesellschaft M.B.H. · 5 register entries
- OramorphL. Molteni And C. Dei F.Lli Alitti Società Di Esercizio S.P.A. · 1 register entry
- SubstitolMundipharma Gesellschaft M.B.H. · 1 register entry
- VendalG.L. Pharma Gmbh · 4 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- CaprosEthypharm · 3 register entries
- M-BetaBetapharm Arzneimittel Gmbh · 1 register entry
- M-LongEthypharm · 1 register entry
- M-StadaStadapharm Gmbh · 3 register entries
- MolnexKalceks · 1 register entry
- MorphinAliud Pharma Gmbh, Merck Healthcare Germany Gmbh, Aristo Pharma Gmbh (Art 57), Ratiopharm Gmbh, G.L. Pharma Gmbh, Ps Marketing And Outsourcing Gmbh, Ps Marketing Und Outsourcing Gmbh, Laboratórios Basi – Indústria Farmacêutica, S.A. · 18 register entries
- Morphinsulfat AbzAbz-Pharma Gmbh · 1 register entry
- Morphinsulfat DopiopharmPs Marketing Und Outsourcing Gmbh · 1 register entry
- Morphinsulfat GryTeva Gmbh · 5 register entries
- Morphinsulfat HamelnHameln Pharma Gmbh · 1 register entry
- MsiMundipharma Gmbh · 1 register entry
- MstMundipharma Gmbh · 2 register entries
Show all 18 brand names
- OramorphL. Molteni And C. Dei F.Lli Alitti Società Di Esercizio S.P.A. · 2 register entries
- PainbreakPb Pharma Gmbh · 1 register entry
- RemosanG.L. Pharma Gmbh · 1 register entry
- SendolorEurocept International Bv · 1 register entry
- SevredolMundipharma Gmbh, Pb Pharma Gmbh · 2 register entries
- SubstitolMundipharma Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- Hazir EnjektorNOBEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- M-EslonNOBEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- MorfiaİLKO İLAÇ SAN.VE TİC. A.Ş. · 7 register entries
- Morfin Hidroklorür OselOSEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- MORPHINE HClGALEN İLAÇ SAN.VE TİC.A.Ş · 2 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
USA
- DuramorphHikma Pharmaceuticals USA Inc. · 1 register entry
- Infumorph 200Hikma Pharmaceuticals USA Inc. · 1 register entry
- Infumorph 500Hikma Pharmaceuticals USA Inc. · 1 register entry
- MitigoPiramal Critical Care, Inc. · 1 register entry
- MS ContinRhodes Pharmaceuticals LLC · 1 register entry
Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28
Brand names in 26 more European countries
- Belgium
- Morphine Hcl Sterop, Morphine Teva, Ms Contin, Ms Direct
- Bulgaria
- Substitol, Морфин Софарма, Субститол
- Croatia
- Morfinklorid Alkaloid, Mst Continus, Oramorph, Sevredol
- Cyprus
- Sevredol
- Czechia
- Morphin Bbp, Morphine Kalceks, Sevredol, Vendal Retard
- Denmark
- Contalgin, Depolan, Doltard, Malfin, Morfin Abcur, Morfin Dak, Morfin Dlf, Morfin Eql Pharma, Morfin Sad, Oramorph, Sendolor
- Estonia
- Mxl, Sevredol, Vendal Retard
- Finland
- Molnex, Morphin Evolan Pharma, Morphine Hydrochloride Evolan Pharma, Sendolor
- France
- Actiskenan, Lunetra, Molnex, Morphine (Chlorhydrate) Aguettant, Morphine (Chlorhydrate) Cooper, Morphine (Chlorhydrate) Lavoisier, Morphine (Chlorhydrate) Renaudin, Morphine (Sulfate) Lavoisier, Moscontin, Oramorph, Sevredol, Skenan L.P., Sulfate De Morphine Lp Ethypharm
- Hungary
- Morphine Kalceks, Morphinum Hydrochloricum Teva, Mst Continus, Sevredol
- Iceland
- Contalgin, Morfin Abcur, Morphine Sulfate Kalceks
- Ireland
- Morphine Sulfate As Kalceks, Morphine Sulfate Mercury Pharmaceuticals (Ireland), Morphine Sulphate Ethypharm, Morphine Sulphate Mercury Pharmaceuticals (Ireland), Mst Continus, Oramorph, Sevredol
- Italy
- Morfina Cloridrato Molteni, Morfina Cloridrato Monico, Morfina Cloridrato S.A.L.F, Morfina Cloridrato S.A.L.F., Ms Contin, Oramorph, Twice
- Latvia
- Morfīna Hidrohlorīds Kalceks, Vendal Retard
- Lithuania
- Morphine Hydrochloride Kalceks, Vendal Retard
- Luxembourg
- Morphine Hcl Sterop, Ms Contin, Ms Direct, Oramorph, Sendolor
- Malta
- Molnex, Morphine Hydrochloride Monico, Morphine Sulfate As Kalceks
- Netherlands
- Lunetra, Molnex, Morfine Hcl Cf, Morfine Hcl Expharma, Morfine Hcl Focus, Morfine Hcl Retard Cf, Morfine Hcl Teva, Morfine Kalceks, Morfine Sulphate Aurobindo, Morfinesulfaat Teva, Sendolor
- Norway
- Malfin, Morfin Abcur, Morfin Epidural, Morfin Orifarm, Relifine
- Poland
- Autostrzykawka Morfina Przeciwko Bólowi Zpsm Ravimed, Morphine Kalceks, Mst Continus, Oramorph, Sevredol, Vendal Retard
- Portugal
- Morfina, Mst, Oramorph, Sevredol, Zomorph
- Romania
- Morfină Zentiva, Sevredol, Vendal Retard
- Slovakia
- Morphin Bbp, Morphine Kalceks, Mst Continus, Sevredol
- Slovenia
- Morfin Alkaloid-Int, Oramorph, Sevredol, Substitol
- Spain
- Morfina B. Braun, Morfina Serra, Mst Continus, Oramorph, Sevredol
- Sweden
- Depolan, Lacedor, Morfin Abcur, Morfin Alternova, Morfin Kalceks, Morfin Viatris, Morphine Unimedic, Sendolor
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Morphine Sulfate (Hikma Pharmaceuticals USA Inc.) – Prescribing Information, 2026-02-03. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c847554-3b4b-4d24-a145-2ef7e9b83699
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/
- Wikidata (CC0): ATC N02AA.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.